XLRN Acceleron Pharma Inc

Acceleron Pharma Inc is a biotechnology company which focuses on discovery, development, and commercialization of novel therapies. It aims to discover key natural regulators of cellular growth and repair.

$173.75  -0.03 (-0.02%)
As of 10/26/2021 15:59:51 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/19/2013
Outstanding shares:  60,900,521
Average volume:  2,016,260
Market cap:   $10,593,645,628
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00434H108
ISIN:        US00434H1086
Valuation   (See tab for details)
PE ratio:   -47.32
PB ratio:   13.84
PS ratio:   104.76
Return on equity:   -29.31%
Net income %:   -221.14%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy